Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01088555 · ClinicalTrials.gov registry record · NA
Effect of Sodium Thiosulfate on Urine Chemistries of Hypercalciuric Stone Formers
A NA study, sponsored by VA New York Harbor Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01088555 is a NA study that has completed, run by VA New York Harbor Healthcare System. The registered enrollment target is 10 participants.
The verdict
NCT01088555, a NA study, has completed, sponsored by VA New York Harbor Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Sodium thiosulfate may be useful to prevent recurrence of calcium-containing kidney stones. It will be studied in people with high amounts of urine calcium.
Interventions
- DRUG Sodium thiosulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01088555
The ClinicalTrials.gov registry entry for NCT01088555 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA New York Harbor Healthcare System, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sodium thiosulfate is the first listed.
NCT01088555 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01088555 about?
NCT01088555 is a clinical study titled "Effect of Sodium Thiosulfate on Urine Chemistries of Hypercalciuric Stone Formers". Sodium thiosulfate may be useful to prevent recurrence of calcium-containing kidney stones. It will be studied in people with high amounts of urine calcium.
What is the current status of trial NCT01088555?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2009-11. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01088555?
The interventions under investigation include: Sodium thiosulfate (DRUG).
Who is sponsoring clinical trial NCT01088555?
This trial is sponsored by VA New York Harbor Healthcare System, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.